Stockscreener 앱 받기
2.24%
시간 외 거래:
Pfizer Inc 주식(PFE)의 최신 뉴스
Pfizer Stock After Hours (PFE) on Dec. 15, 2025: What Moved Shares Today—and What to Watch Before Tuesday’s Open - ts2.tech
Pfizer (NYSE:PFE) Stock Price Up 2.3% After Dividend Announcement - MarketBeat
Pfizer (PFE) Valuation Check After Positive Phase 3 Wins and New Obesity Drug Licensing Deal - simplywall.st
Pfizer Stock (PFE) News, Forecasts, and Analyst Outlook: What’s Driving Shares on December 15, 2025 - ts2.tech
What's Going On With Pfizer Stock Monday?Pfizer (NYSE:PFE) - Benzinga
Adaptive signs deal with Pfizer worth up to $890 million for rheumatoid arthritis research - Reuters
Adaptive Biotechnologies inks two agreements with Pfizer in immunology - Investing.com
Adaptive Biotechnologies inks two agreements with Pfizer in immunology By Investing.com - Investing.com UK
Adaptive Biotechnologies stock rises after Pfizer deals worth up to $890M - Investing.com Canada
Adaptive Biotechnologies stock rises after Pfizer deals worth up to $890M By Investing.com - Investing.com South Africa
Adaptive Biotechnologies announces two immune receptor licensing agreements with Pfizer - PharmaLive
Adaptive Biotechnologies signs two immune receptor licensing deals with Pfizer - marketscreener.com
Watts Gwilliam & Co. LLC Buys 50,744 Shares of Pfizer Inc. $PFE - MarketBeat
Adaptive Biotechnologies Signs Target Discovery, Licensing Deals With Pfizer - marketscreener.com
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know - Yahoo Finance
ANALYSIS: Novo’s Novel GLP-1 Bid Failed But That’s Not the Point - Bloomberg Law News
Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million - marketscreener.com
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer - Yahoo Finance
Pfizer Stock (PFE) News Today: Dividend, 2026 Guidance Call, Obesity Deals, and Analyst Forecasts (Dec. 15, 2025) - ts2.tech
Pfizer’s Hold Rating: Navigating Loss of Exclusivity and Flat Growth Prospects - TipRanks
47,996 Shares in Pfizer Inc. $PFE Acquired by MASTERINVEST Kapitalanlage GmbH - MarketBeat
Marex Group plc Purchases Shares of 65,461 Pfizer Inc. $PFE - MarketBeat
Will Dogecoin Reach $1 By the End of the Year? - The Motley Fool
Pfizer Declares First-Quarter 2026 Dividend - BioSpace
Cullen Capital Management LLC Has $88.32 Million Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next - ts2.tech
Pfizer Stock (PFE) Before Market Open Dec. 15, 2025: Key News, 2026 Guidance Call, Analyst Targets, Dividend, and Risks - ts2.tech
Pfizer’s New Phase 1 Study: A Potential Breakthrough for Kidney Disease Treatment - TipRanks
Orion Porfolio Solutions LLC Has $17.19 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Stock (PFE) Outlook: This Week’s Key Headlines, Dividend Update, and What to Watch Ahead of 2026 Guidance (Updated Dec. 14, 2025) - ts2.tech
Evergreen Capital Management LLC Purchases 63,611 Shares of Pfizer Inc. $PFE - MarketBeat
Forget Teladoc and Buy This Healthcare Stock Instead - Yahoo Finance
Bellevue Group AG Reduces Holdings in Pfizer Inc. $PFE - MarketBeat
Banque Transatlantique SA Lowers Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by Adage Capital Partners GP L.L.C. - MarketBeat
Pfizer (PFE) Stock After Hours on Dec. 12, 2025: Dividend Update, FDA “Black Box” Headline, Analyst Forecasts — What to Know Before the Next Market Open - ts2.tech
Pfizer (PFE) Stock After Hours on Dec. 12, 2025: Dividend Update, FDA Vaccine Warning Headlines, and What to Watch Before the Next Market Open - ts2.tech
Pfizer Inc. Declares First-Quarter 2026 Dividend, Payable on March 6, 2026 - marketscreener.com
Pfizer declares $0.43 quarterly dividend payable in March 2026 - Investing.com
Pfizer declares $0.43 quarterly dividend payable in March 2026 By Investing.com - Investing.com Canada
Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. - The Globe and Mail
The Best Turnaround Stock to Invest $1,000 in Right Now - Finviz
Is Pfizer Shifting From Defensive Stock To Value Opportunity After Post Pandemic Restructuring? - simplywall.st
Treasurer of the State of North Carolina Purchases 520,580 Shares of Pfizer Inc. $PFE - MarketBeat
Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial - Reuters
NewEdge Advisors LLC Acquires 97,789 Shares of Pfizer Inc. $PFE - MarketBeat
Morgan Stanley Adjusts Price Target on Pfizer to $28 From $32, Maintains Equalweight Rating - marketscreener.com
CIBC Asset Management Inc Trims Stock Position in Pfizer Inc. $PFE - MarketBeat
Camber Capital Management LP Has $36.36 Million Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. - Britannica
Bayesian Capital Management LP Sells 55,000 Shares of Pfizer Inc. $PFE - MarketBeat
Elevance Health Adds Former Pfizer GC To Its Board - Law360
Pfizer (PFE) Stock Outlook After the November 21 FDA Win: Obesity Deals, Cost Cuts and a 6.7% Dividend Yield - ts2.tech
Ex-Pfizer executive joins Elevance’s board as insurer pursues pharmacy experience - Healthcare Dive
Pfizer plans job cuts in Switzerland to reduce expenses - Yahoo Finance
Pfizer's cost-cutting drive reaches Switzerland, where company plans to lay off hundreds by year-end: Bloomberg - Fierce Pharma
Down 50%, should you buy the dip on Pfizer? - MSN
Pfizer Inc. (PFE) Announces Results from Phase 3 BASIS Study - Finviz
Pfizer Inc. $PFE Shares Sold by Schwerin Boyle Capital Management Inc. - MarketBeat
IDEAYA Biosciences Completes Targeted Full Enrollment in Trial of Darovasertib With Pfizer's Crizotinib - marketscreener.com
Will Obesity Bet and TUKYSA Data Shift Pfizer’s (PFE) Post-COVID Growth Narrative? - simplywall.st
Pfizer Inc. $PFE Shares Sold by Marshall Wace LLP - MarketBeat
Pfizer Inc. $PFE Shares Sold by Becker Capital Management Inc. - MarketBeat
How the Narrative Surrounding Pfizer Is Changing After Obesity Deals and Sector Rerating - Yahoo Finance
Pfizer Plans Workforce Reduction in Switzerland - marketscreener.com
Pfizer Could Claim Tukysa First-Line HER2+ Metastatic Breast Cancer Indication - Citeline News & Insights
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
0.51%
2.38%
자본화:
|
볼륨(24시간):